Clinical Trial Update: EGFR-TKI Resistance Profile in Chinese Patients With Advanced EGFRm+ NSCLC

View source ↗

Summary

This clinical trial update describes observations on resistance patterns to EGFR tyrosine kinase inhibitors in Chinese patients with advanced EGFR-mutant non-sm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Jianxing He | Conditions: Nonsmall Cell Lung Cancer | Status: UNKNOWN